Table 2 Adverse clinical outcomes and results of the Cox proportional regression model according to tertile of baseline alanine aminotransferase level.
Variable | Univariate analysis | Multivariate analysis** | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Stroke | ||||
ALT as a categorical variable (first vs second and third tertile*) | 0.96 (0.65–1.40) | 0.85 | 0.83 (0.56–1.23) | 0.36 |
ALT as a continuous variable (per 1 U/L increase) | 1.00 (0.98–1.01) | 0.94 | 1.00 (0.99–1.01) | 0.35 |
Major bleeding | ||||
ALT as a categorical variable (first vs second and third tertile*) | 1.18 (0.81–1.69) | 0.37 | 1.08 (0.73–1.560) | 0.68 |
ALT as a continuous variable (per 1 U/L increase) | 1.00 (0.99–1.01) | 0.60 | 1.00 (0.99–1.01) | 0.28 |
Cardiovascular mortality | ||||
ALT as a categorical variable (first vs second and third tertile*) | 2.26 (1.49–3.41) | < 0.001 | 1.69 (1.10–2.59) | 0.016 |
ALT as a continuous variable (per 1 U/L increase) | 0.97 (0.94–0.99) | 0.006 | 0.98 (0.96–1.01) | 0.23 |
All-cause mortality | ||||
ALT as a categorical variable (first vs second and third tertile*) | 1.96 (1.48–2.60) | < 0.001 | 1.53 (1.14–2.04) | 0.003 |
ALT as a continuous variable (per 1 U/L increase) | 0.96 (0.94–0.98) | < 0.001 | 0.98 (0.96–0.99) | 0.015 |